NEUROTECH INTERNATIONAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.065 AUD | -8.45% |
|
-12.16% | -5.80% |
| Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
| Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 0.0830 | 0.1200 | 0.1200 |
| Spread/Res. | -21.69% | -45.83% | -45.83% |
| Spread/Supp. | +0.00% | +18.18% | +6.56% |
| Support | 0.0650 | 0.0550 | 0.0610 |
- Stock Market
- Equities
- NTI Stock
- Charts Neurotech International Limited
